{ }
001122334455554433221100
001122334455554433221100

Edwards Lifesciences Corporation Focuses on Cardiovascular Medical Devices and Systems

Edwards Lifesciences Corporation focuses on designing, manufacturing, and marketing medical systems and devices for cardiovascular disease treatment. Their product sales are primarily from heart valves and cardiac surgery products (67.9%), followed by hemodynamic monitoring systems (15.5%) and other devices (16.6%). Geographically, 58.4% of sales occur in the United States, with Europe at 22.2%, Japan at 7.6%, and other regions at 11.8%.
15:04 05.12.2024

Edwards Lifesciences Reports Neutral UBS Recommendation Amid Strong Cardiovascular Device Sales

Edwards Lifesciences Corporation focuses on developing and marketing medical systems for cardiovascular diseases, with net sales primarily from heart valves and surgical products (67.9%) and hemodynamic monitoring systems (15.5%). Geographically, the company generates 58.4% of its sales in the United States, followed by Europe (22.2%), Japan (7.6%), and other regions (11.8%). UBS maintains a neutral recommendation on the stock.
15:04 05.12.2024

hi-tech medical devices market poised for growth driven by innovation and sustainability

The global Hi-Tech Medical Devices Market is experiencing significant growth driven by technological advancements, changing consumer preferences, and a focus on sustainability. Key objectives include forecasting market size across regions, analyzing growth factors, and identifying opportunities for stakeholders. Major players in the market include Medtronic, Abbott Laboratories, and Johnson & Johnson, with a comprehensive analysis of competitive dynamics and market trends provided in the research report.

medical device industry sees significant mergers and acquisitions in 2024

In 2024, the medical device manufacturing sector witnessed significant mergers and acquisitions, highlighting ongoing consolidation trends. Notable transactions included Boston Scientific's $3.7 billion acquisition of Axonics and Roche's $295 million deal for LumiraDx's Point of Care technology. Other key players like GE Healthcare and Edwards Lifesciences also expanded their portfolios through strategic acquisitions, enhancing their capabilities in various medical fields.

congress aims to enhance medicare coverage for breakthrough medical technologies

Congress is urged to act this fall to enhance Medicare coverage for breakthrough medical technologies, as current policies are insufficient. While the FDA's expedited review process for innovative devices exists, Medicare's slow coverage can delay access for millions of beneficiaries, particularly those in underserved communities. Legislative efforts, such as H.R. 1691, aim to provide a more comprehensive solution, promoting health equity and encouraging medtech innovation.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.